107 related articles for article (PubMed ID: 34271222)
21. Molecular mechanisms of insulin resistance in 2 cases of primary insulin receptor defect-associated diseases.
Tsuji-Hosokawa A; Takasawa K; Nomura R; Miyakawa Y; Numakura C; Hijikata A; Shirai T; Ogawa Y; Kashimada K; Morio T
Pediatr Diabetes; 2017 Dec; 18(8):917-924. PubMed ID: 28181734
[TBL] [Abstract][Full Text] [Related]
22. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
23.
Luo P; Zheng M; Zhang R; Zhang H; Liu Y; Li W; Sun X; Yu Q; Tipoe GL; Xiao J
Acta Pharm Sin B; 2021 Mar; 11(3):668-679. PubMed ID: 33777674
[TBL] [Abstract][Full Text] [Related]
24. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
25. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.
Haas JT; Miao J; Chanda D; Wang Y; Zhao E; Haas ME; Hirschey M; Vaitheesvaran B; Farese RV; Kurland IJ; Graham M; Crooke R; Foufelle F; Biddinger SB
Cell Metab; 2012 Jun; 15(6):873-84. PubMed ID: 22682225
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.
Sim WC; Lee W; Sim H; Lee KY; Jung SH; Choi YJ; Kim HY; Kang KW; Lee JY; Choi YJ; Kim SK; Jun DW; Kim W; Lee BH
Metabolism; 2020 Jan; 102():154000. PubMed ID: 31678070
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
29. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
30. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
31. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
32. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels.
Nagarajan A; Petersen MC; Nasiri AR; Butrico G; Fung A; Ruan HB; Kursawe R; Caprio S; Thibodeau J; Bourgeois-Daigneault MC; Sun L; Gao G; Bhanot S; Jurczak MJ; Green MR; Shulman GI; Wajapeyee N
Nat Commun; 2016 Aug; 7():12639. PubMed ID: 27577745
[TBL] [Abstract][Full Text] [Related]
33. SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice.
Nguyen TTP; Kim DY; Lee YG; Lee YS; Truong XT; Lee JH; Song DK; Kwon TK; Park SH; Jung CH; Moon C; Osborne TF; Im SS; Jeon TI
Mol Cell; 2021 Sep; 81(18):3820-3832.e7. PubMed ID: 34233158
[TBL] [Abstract][Full Text] [Related]
34. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
[TBL] [Abstract][Full Text] [Related]
35. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
36. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
37. Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease
Liu H; Chen Y; Wen Y; Zhu S; Huang S; He L; Hou S; Lai X; Chen S; Dai Z; Liang J
J Agric Food Chem; 2021 Aug; 69(31):8671-8683. PubMed ID: 34342231
[TBL] [Abstract][Full Text] [Related]
38. Estrogen-related receptor γ controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver.
Kim DK; Kim YH; Lee JH; Jung YS; Kim J; Feng R; Jeon TI; Lee IK; Cho SJ; Im SS; Dooley S; Osborne TF; Lee CH; Choi HS
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158521. PubMed ID: 31479733
[TBL] [Abstract][Full Text] [Related]
39. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
[TBL] [Abstract][Full Text] [Related]
40. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
